GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Serina Therapeutics Inc (AMEX:SER) » Definitions » FCF Yield %

Serina Therapeutics (Serina Therapeutics) FCF Yield % : -13.52 (As of May. 16, 2024)


View and export this data going back to 2024. Start your Free Trial

What is Serina Therapeutics FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Serina Therapeutics's Trailing 12-Month Free Cash Flow is $-3.12 Mil, and Market Cap is $22.08 Mil. Therefore, Serina Therapeutics's FCF Yield % for today is -13.52%.

The historical rank and industry rank for Serina Therapeutics's FCF Yield % or its related term are showing as below:

SER' s FCF Yield % Range Over the Past 10 Years
Min: -15.61   Med: 0   Max: 0
Current: -13.52

SER's FCF Yield % is ranked worse than
50.9% of 1554 companies
in the Biotechnology industry
Industry Median: -14.48 vs SER: -13.52

Serina Therapeutics's FCF Margin % for the quarter that ended in Jun. 2023 was 0.00%.

Serina Therapeutics FCF Yield % Historical Data

The historical data trend for Serina Therapeutics's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Serina Therapeutics FCF Yield % Chart

Serina Therapeutics Annual Data
Trend Dec21 Dec22
FCF Yield %
- -

Serina Therapeutics Semi-Annual Data
Dec21 Jun22 Dec22 Jun23
FCF Yield % - - - -

Competitive Comparison of Serina Therapeutics's FCF Yield %

For the Biotechnology subindustry, Serina Therapeutics's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Serina Therapeutics's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Serina Therapeutics's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Serina Therapeutics's FCF Yield % falls into.


Serina Therapeutics FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Serina Therapeutics's FCF Yield % for the fiscal year that ended in Dec. 2022 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-2.086 / 0
=N/A%

Serina Therapeutics's annualized FCF Yield % for the quarter that ended in Jun. 2023 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-1.888 * 2 / 0
=N/A%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Serina Therapeutics FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Serina Therapeutics FCF Yield % Related Terms

Thank you for viewing the detailed overview of Serina Therapeutics's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Serina Therapeutics (Serina Therapeutics) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Serina Therapeutics Inc (AMEX:SER) » Definitions » FCF Yield %
Comparable Companies
Traded in Other Exchanges
N/A
Address
601 Genome Way, Suite 2001, Huntsville, AL, USA, 35806
Website
https://www.serinatherapeutics.com
Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers.

Serina Therapeutics (Serina Therapeutics) Headlines

From GuruFocus

Enable Injections and Serina Therapeutics Announce Agreement to Develop SER-252 in Combination with enFuse� for Advanced Parkinson's Disease

By Marketwired • 05-15-2024